Authors:
FLASKO A
PATEL H
BUTCHERT A
GUTHRIE W
FIELDING M
OSHAUGHNESSY T
HEPPLER L
KLEIN R
GARABADIAN C
MELKONIAN R
DURST M
BARKETT G
SPAHL T
BIGGS J
MORRIS L
KRAJACK R
FRONDA M
COLLINS T
GARRY J
BIXBY G
CUSACK B
FARRELL J
DEAN T
MILLER D
ELLIS A
EATMON R
HOLLEMAN S
TRUITT JW
LAUSON SK
PHILLIPS D
CHAN C
ORENS S
ESHLEMAN J
PETERS R
LEWIS H
KOZAN D
TILLEY L
GOAD A
HOPKINS M
FONTANA V
DUHAMEL J
OLSON G
JAKSHA S
KLEMONS I
VARGO C
WITZIG J
POLKE K
BARRETT P
MAYES J
HAZE J
KELLER D
KLOCKOW G
KELLER R
Citation: A. Flasko et al., MANAGING TMD, The Journal of the American Dental Association, 128(2), 1997, pp. 146
Authors:
WANG CY
ESHLEMAN J
LUTTERBAUGH J
YANG B
WILLSON J
MARKOWITZ S
Citation: Cy. Wang et al., SPONTANEOUS APOPTOSIS IN HUMAN COLON-TUMOR CELL-LINES AND THE RELATION OF WT P53 TO APOPTOSIS, Chinese medical journal, 109(7), 1996, pp. 537-541
Authors:
EMRICH JG
BENDER H
CLASS R
ESHLEMAN J
MIYAMOTO C
BRADY LW
Citation: Jg. Emrich et al., IN-VITRO EVALUATION OF IODINE-125-LABELED MONOCLONAL-ANTIBODY (MAB-425) IN HUMAN HIGH-GRADE GLIOMA-CELLS, American journal of clinical oncology, 19(6), 1996, pp. 601-608
Authors:
KLINE RH
ESHLEMAN J
WRIGHT J
ELDEFRAWI ME
Citation: Rh. Kline et al., SYNTHESIS OF SUBSTITUTED S-CARBAMOYLECGONINE METHYL-ESTER ANALOGS - IRREVERSIBLE AND PHOTOAFFINITY LIGANDS FOR THE COCAINE RECEPTOR DOPAMINE TRANSPORTER, Journal of medicinal chemistry, 37(14), 1994, pp. 2249-2252
Authors:
GUERRIERI P
BRADY LW
MIYAMOTO C
RACKOVER M
EMRICH J
WOO D
BENDER H
ESHLEMAN J
STEPLEWSKI Z
KOPROWSKI H
Citation: P. Guerrieri et al., IMMUNORADIOTHERAPY WITH 125-I LABELED MONOCLONAL-ANTIBODIES IN ADVANCED NEOPLASTIC DISEASES, International journal of radiation oncology, biology, physics, 27, 1993, pp. 318-319